medigraphic.com
ISSN 1405-8871 (Print)

2013, Number 3

<< Back Next >>

Aten Fam 2013; 20 (3)

Frequency of “High Risk of Developing Diabetes” in Patients Attending a Family Medicine Clinic

Ortiz-Contreras E, Baillet-Esquivel LE, Ponce-Rosas ER, Sánchez- Escobar LE, Santiago-Baena G, Landgrave-Ibáñez S

Language: Spanish
References: 21
Page: 77-80
PDF size: 258.68 Kb.


ABSTRACT

Objective: to identify the frequency of pre-diabetes in patients between 20 to 64 years at the outpatient “Gustavo A. Madero” Family Medicine Clinic, in Mexico City. Method: Study: descriptive, cross-sectional, prospective. Population: non-random and non-representative sample (123 patients). Instrument: 35 variables distributed in four sections: tab identification, laboratory parameters, clinical data and a questionnaire endorsed by the American Diabetes Association (ada). Measurement: a measurement of glucose in venous blood and direct examination to those patients who agreed to participate. Results: a pre-diabetes frequency of 43.9% was found, 65.2% of the patients presented a (bmi) ›30 (n=30). Important statistically differences were found in patients with high blood pressure and pre-diabetes compared to those without high blood pressure but with high risk of developing diabetes (redd), Pearson χ2 of 13.422, p=0.001. More than 70% of patients do not carry a balanced diet or physical exercise. Conclusions: the family physician should be able to timely detect the existence of REDD in order to prevent or delay Diabetes mellitus type 2. This could increase in patients both hope and quality of life.


REFERENCES

  1. Norma Oficial Mexicana nom-015-ssa2-2010. Para la prevención, tratamiento y control de la diabetes mellitus. Comité Consultivo Nacional de Normalización de Prevención y Control de Enfermedades, 23 de noviembre de 2010.

  2. Guía Práctica Clínica imss. Diagnóstico y Tratamiento de la Diabetes Mellitus Tipo 2 en el primer nivel de atención; 2009.

  3. Pérez-Jáuregui J, Reza-Albarrán A, González-Cardel G. Importancia de la actualización en México del criterio de glucosa en ayuno alterada. Rev. Med. Inst. Mex. Seguro Soc. 2009;47(4):357-62.

  4. American Diabetes Association. Summary of Revisions for the 2010 Clinical Practice Recomendations. Diabetes Care. 2010;33(Suppl 1):3-5.

  5. American Diabetes Association. Standard of Medical Care in Diabetes 2011. Rev. Diabetes Care. 2011;34(Suppl 1):62-9.

  6. American Diabetes Association. Standard of Medical Care in Diabetes 2012. Rev. Diabetes Care. 2012 January;32.

  7. Holmes NH, Robinson H, Tschesholg B. Diabetes Mellitus guía para el manejo del paciente. Barcelona: Lippincott, Wilkins Williams; 2007.

  8. Ministerio de Sanidad y Consumo. Estrategia en Diabetes del Sistema Nacional de Salud España. 2007:11-49.

  9. Guía Práctica Clínica imss. Diagnóstico y Tratamiento y Prevención del Sobrepeso y la Obesidad en el Adulto; 2009.

  10. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabetic Medicine. 2007;24:451-63.

  11. Bastarrechea RA, Laviada MH, Vázquez CHC. Análisis crítico de los nuevos criterios que sustentan el diagnóstico de pre-diabetes. Revista de Endocrinología y Nutrición. 2004;12(2):90-6.

  12. Munguía MC, Sánchez BR, Tuz K, Alonso GA, Cruz M. Detección de glucosa en ayuno alterada en donadores de sangre. Rev. Med. Inst. Mex. Seguro Soc. 2009;47(1):17-24.

  13. Parikh MPH, Ellen P, Kezhen FMS, Helen LMD, Crispín-Goytia BS, Horowitz CMD, et al. Results of a Pilot Diabetes Prevention Intervention in East Harlem, New York City: Project heed. American Journal of Public Health. 2010;100(Suppl 1):S232- S239.

  14. Gullies LC, Keith RA, Lambert CP, Nicola JC, Sutton JA, Hsul RT, et al. Intervenciones farmacológicas y en el estilo de vida para prevenir o retrasar la aparición de diabetes tipo 2 en personas con alteraciones en la tolerancia a la glucosa: análisis sistemático y metaanálisis. bmj (Ed. Esp). 2008;2(Suppl 2):104-12.

  15. American Diabetes Association. Standard of Medical Care in Diabetes 2009. Rev. Diabetes Care. 2009 January;32(Suppl 1):S13-S17.

  16. Gómez DA, Wacher RN, Aguilar SC. Sistema de Actualización Médica en Diabetes (sam). México; 2008.

  17. Gupta AK, Johnson DW. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. Journal of Inflammation. 2010;7:36.

  18. Asociación Americana de Diabetes (usa) [Internet]; 2010 [citado 2011 enero 10]. Disponible en: www. diabetes.org/risk-test.jsp

  19. Asociación Latinoamericana de Diabetes Alad. Prevención primaria de diabetes tipo 2. Rev. de la Alad. 2011;19(1):17-28.

  20. Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, et al. Diagnosis and Management of prediabetes in the continuum of hyperglycemia- when do the risk of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologist. Prediabetes Consensus Statement. Endocr Pract. 2008;14(7):933-44.

  21. Zimet P. Consenso de la fid para la prevención de la diabetes tipo 2. Diabetes Hoy Med Sal. 2007;8(5):1890-3.




2020     |     www.medigraphic.com